| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.096 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |